Overview Aging has a biology, and this biology drives age-related diseases (Geroscience). We at Einstein have demonstrated that the biology of aging can be targeted in experimental models to delay, stop, and in some examples, reverse manifestations of aging. Our overarching Mission is to make scientific discoveries in geroscience, leveraging on the expertise in our center in studying and targeting the pillars of aging, and to confirm their relevance of new findings to human aging through the unique Gero-human resource created in our center and to translate interventions proven relevant for human to drug discovery efforts. Centers of Excellence The institute for Aging Research is the home of two aging centers of international recognition. The Nathan Shock Center of Excellence, focused on the study of the biology of aging and the Einstein Paul F. Glenn Center solely dedicate to understanding the biology behind human Aging. Learn More Nathan Shock Center of Excellence LEARN MORE The Paul F. Glenn Center for Biology of Human Aging LEARN MORE Research Integrative Physiology Dietary strategies to delay aging Metabolism targeting to delay aging Cell autonomous and non-autonomous aging CNS control of metabolism and aging Cell Biology of Aging Proteostasis DNA repair Response to Stress Inflammaging Stem Cells Genetics of Aging Human Longevity Comparative genomics of longevity Translational Geroscience TAME Human Longevity Studies Clinical Geriatrics Training Einstein's Institute for Aging Research is committed to the development the next generation scientists in the biology of aging. Training programs are available for graduate and postdoctoral candidates. Learn More Multimedia Nir Barzilai, MD - Harvard FUSION Symposium 2019 More Videos Highlights News Release Albert Einstein College of Medicine Receives $16 Million NIH Grant to Study Cellular Process Linked to Alzheimer’s Disease Sep 08, 2020 Feature Unlocking the Secrets of Longevity: 20 Years of Centenarian Research at Einstein Feb 22, 2019 News Release Einstein Receives $6 Million Grant to Untangle the Genetic Protections Against Alzheimer's Disease Nov 13, 2017 See All Events More Events 20 January Jan IP & Coffee Seminar Series: Invention Reporting - Policy Changes | What Your Federal Grants Require? Wed Jan 20 2021, 3:00 PM Speaker: Bethany H. LoftinInteragency Policy & iEdison Specialist National Institute of Standards and Technology Virtual, Zoom: https://tinyurl.com/IPandCoffee-1 nilam.sinha@einsteinmed.org More Zoom registration link: https://tinyurl.com/IPandCoffee-1 Publications See More A Comprehensive Management of Complicated Anterior Maxillary Crown Fracture in a 15-year-old Adolescent.A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin.Shear stress turns on the primary cilium and lipophagy.Similar burden of pathogenic coding variants in exceptionally long-lived individuals and individuals without exceptional longevity.Remembering Beth Levine - the autophagy pioneer and woman extraordinaire.Geroscience in the Age of COVID-19.Plasma proteomic profile of frailty.FOXO3a acts to suppress DNA double-strand break-induced mutations.Genetics of extreme human longevity to guide drug discovery for healthy ageing.Elucidating the mechanisms by which disulfiram protects against obesity and metabolic syndrome.